NORWALK, Conn., Jan. 11, 2016 /PRNewswire/ -- In a newly released survey conducted by HealthPrize Technologies, an industry-leading medication adherence and digital patient engagement company, medication adherence experts across varied fields shared their views on advances in – and challenges of – current research. Specifically, what has moved the needle, what remains in need of greater depth of knowledge, and what misperceptions may cause roadblocks along the way.
"Insights gained from our interviews challenge the results of decades of study, reinforcing the idea that medication adherence research is ever-evolving," says Katrina Firlik, MD, co-founder and Chief Medical Officer of HealthPrize. "From understanding adherence patterns, to the shifting ways in which we target patients for adherence intervention, to the metrics we use to inform research are up for perpetual debate. At the same time, however, I believe that real forward progress is being made."
Among the insights offered by the expert panel were thoughts on group-based trajectory models to measure adherence longitudinally, personalized interventions to avoid the one-size-fits-all approach, and inherent inaccuracies found in current adherence measurement metrics.
Participants interviewed by HealthPrize include:
Hayden B. Bosworth, PhD – Associate Director, Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; Research Professor, Department of Medicine, Division of General Internal Medicine, Department of Psychiatry and Behavioral Sciences, School of Nursing, Duke University Medical Center
Jessica Franklin, PhD – Assistant Professor of Medicine, Harvard Medical School; Biostatistician, Division of Pharmacoepedmiology and Pharmacoeconomics, Brigham and Women's Hospital
Walid Gellad, MD, MPH – Associate Professor of Medicine, School of Medicine, Assistant Professor of Health Policy and Management, School of Public Health, University of Pittsburgh
Ian M. Kronish, MD – Assistant Professor, Division of General Medicine, Columbia University Medical Center
Wei-Hsuan Jenny Lo-Ciganic, PhD, MSCP, MS – Assistant Professor, College of Pharmacy, Department of Pharmacy, Practice and Science, University of Arizona
Zachary A. Marcum, PharmD, PhD, BCPS – Assistant Professor, School of Pharmacy, University of Washington
Bernard Vrijens, PhD – Chief Science Officer, WestRock Healthcare
Dr. Firlik's full white paper report on the interviews can be found here: http://bit.ly/1SHWnuF
HealthPrize provides a Software-as-a-Service (SaaS), HIPAA-compliant platform and services to create unique digital experiences proven to drive patient engagement, education and increased medication adherence for healthcare companies and pharmaceutical brands. Using a proprietary gamification approach, and patented technology, combined with a deep understanding of behavioral sciences and patient psychology, HealthPrize consistently delivers high levels of patient engagement resulting in over 50% increased lifts in Rx adherence versus control. For more information, visit www.healthprize.com and follow us on Twitter at @HealthPrize.
Corporate Communications, HealthPrize Technologies
SOURCE HealthPrize Technologies